GandhiV.C., HumayunH.M., IngT.S., DaugirdasJ.T., JablokowV.R., IwatsukiS.Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients.Arch Int Med1980; 140(9): 1201–3.
BalasubramaniamG., BrownE.A., DavenportA., CairnsH., CooperB., FanS.L.The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.Nephrol Dial transplant2009; 24(10): 3209–15.
4.
BrownM.C., SimpsonK., KerssensJ.J., MactierR.A. Scottish Renal Registry. Encapsulating peritoneal sclerosis in the new millennium: a national cohort study.Clin J Am Soc Nephrol2009; 4(7): 1222–9.
KawanishiH., KawaguchiY., FukuiH., HaraS., ImadaA., KuboH.Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study.Am J Kidney Dis2004; 44(4): 729–37.
7.
BrownE.A., Van BiesenW., FinkelsteinF.O., HurstH., JohnsonD.W., KawanishiH.length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD.Perit Dial Int2009; 29(6): 595–600.
8.
De Sousa-AmorimE., Del PesoG., BajoM.A., AlvarezL., OssorioM., GilF.Can EPS development be avoided with early interventions? The potential role of tamoxifen—a single-center study.Perit Dial Int, 2014; 34(6): 582–593.
9.
LoureiroJ., SandovalP., del PesoG., Gonzalez-MateoG., Fernandez-MillaraV., SantamariaB.Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.PloS one2013; 8(4): e61165.
10.
ChungS., ChuW., LeeH., KimY., LeeI., LindholmB.Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients.Perit Dial Int2000; 20(5): 541–7.
11.
RodriguesA.S., AlmeidaM., FonsecaI., MartinsM., CarvalhoM.J., SilvaF.Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation.Nephrol Dial Transplant2006; 21(3): 763–9.
12.
LambieM., ChessJ., DonovanK.L., KimY.L., DoJ.Y., LeeH.B.Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival.J Am Soc Nephrol2013; 24(12): 2071–80.
13.
GoodladC., TamF.W., AhmadS., BhangalG., NorthB.V., BrownE.A.Dialysate cytokine levels do not predict encapsulating peritoneal sclerosis.Perit Dial Int, 2014; 34(6): 594–604.
14.
KorteM.R., FierenM.W., SampimonD.E., LingsmaH.F., WeimarW., BetjesM.G.Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study.Nephrol Dial Transplant2011; 26(2): 691–7.
15.
GuestS.Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experiences.Perit Dial Int2009; 29(3): 252–5.
